Analysts See $0.11 EPS for Lundin Mining (LUN); Eventide Asset Management Has Lowered Kite Pharma (KITE) Position By $906,400

July 21, 2017 - By Michael Collier

Analysts expect Lundin Mining Corporation (TSE:LUN) to report $0.11 EPS on July, 26 after the close.They anticipate $0.14 EPS change or 466.67% from last quarter’s $-0.03 EPS. T_LUN’s profit would be $76.40M giving it 17.64 P/E if the $0.11 EPS is correct. After having $0.17 EPS previously, Lundin Mining Corporation’s analysts see -35.29% EPS growth. The stock decreased 4.32% or $0.35 on July 20, reaching $7.76. About shares traded. Lundin Mining Corporation (TSE:LUN) has 0.00% since July 21, 2016 and is . It has underperformed by 16.70% the S&P500.

Eventide Asset Management Llc decreased Kite Pharma Inc (KITE) stake by 13.86% reported in 2016Q4 SEC filing. Eventide Asset Management Llc sold 20,600 shares as Kite Pharma Inc (KITE)’s stock rose 29.36%. The Eventide Asset Management Llc holds 128,000 shares with $5.74 million value, down from 148,600 last quarter. Kite Pharma Inc now has $6.34 billion valuation. The stock rose 0.10% or $0.11 reaching $110. About 25 shares traded. Kite Pharma Inc (NASDAQ:KITE) has risen 55.47% since July 21, 2016 and is uptrending. It has outperformed by 38.77% the S&P500.

Investors sentiment decreased to 1.31 in Q4 2016. Its down 0.32, from 1.63 in 2016Q3. It is negative, as 34 investors sold KITE shares while 43 reduced holdings. 30 funds opened positions while 71 raised stakes. 43.05 million shares or 17.06% more from 36.77 million shares in 2016Q3 were reported. Solaris Asset Mgmt Lc stated it has 0.02% in Kite Pharma Inc (NASDAQ:KITE). Manufacturers Life Insur Company The holds 0% or 27,035 shares. Td Asset Mngmt Inc has invested 0% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). Airain Ltd invested 0.03% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). Nuveen Asset Mgmt Lc accumulated 0.01% or 24,503 shares. Princeton Alpha Management Limited Partnership holds 0.07% of its portfolio in Kite Pharma Inc (NASDAQ:KITE) for 7,880 shares. Barclays Public Limited Com invested in 0% or 19,873 shares. First Republic Inv Management holds 0.15% of its portfolio in Kite Pharma Inc (NASDAQ:KITE) for 390,419 shares. 345,003 are owned by Geode Cap Lc. Cg Asset Management Limited Co holds 21,625 shares or 0.36% of its portfolio. Voya Inv Management Limited Liability Corporation reported 16,476 shares or 0% of all its holdings. Fortaleza Asset Mngmt invested in 2,070 shares or 0.2% of the stock. Natl Bank Of America De reported 21,015 shares or 0% of all its holdings. Metropolitan Life Ins Ny accumulated 0.01% or 27,967 shares. Prudential Fincl Inc reported 54,940 shares.

Analysts await Kite Pharma Inc (NASDAQ:KITE) to report earnings on August, 14. They expect $-1.87 earnings per share, down 42.75% or $0.56 from last year’s $-1.31 per share. After $-1.74 actual earnings per share reported by Kite Pharma Inc for the previous quarter, Wall Street now forecasts 7.47% negative EPS growth.

Since January 31, 2017, it had 5 insider purchases, and 19 selling transactions for $21.22 million activity. Ruchefsky Steven B had sold 20,000 shares worth $1.79M on Wednesday, June 14. Belldegrun Arie bought $1.17 million worth of stock or 17,000 shares. On Monday, May 1 Kim Helen Susan sold $197,088 worth of Kite Pharma Inc (NASDAQ:KITE) or 2,400 shares. Wiezorek Jeffrey sold $76,820 worth of stock. The insider CHAMPSI FARAH sold 20,450 shares worth $1.84 million. JENKINSON PAUL L also bought $250,427 worth of Kite Pharma Inc (NASDAQ:KITE) on Wednesday, May 10. On Tuesday, May 9 BONDERMAN DAVID bought $3.45 million worth of Kite Pharma Inc (NASDAQ:KITE) or 50,000 shares.

Among 19 analysts covering Kite Pharma (NASDAQ:KITE), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Kite Pharma had 43 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, June 6. The firm has “Outperform” rating by Raymond James given on Thursday, June 2. The stock of Kite Pharma Inc (NASDAQ:KITE) earned “Buy” rating by H.C. Wainwright on Tuesday, February 28. The stock of Kite Pharma Inc (NASDAQ:KITE) earned “Hold” rating by Standpoint Research on Friday, November 13. The firm earned “Mkt Perform” rating on Friday, November 13 by FBR Capital. On Wednesday, January 4 the stock rating was initiated by TH Capital with “Buy”. The firm has “Buy” rating given on Tuesday, June 27 by Canaccord Genuity. As per Monday, July 10, the company rating was maintained by Canaccord Genuity. The stock of Kite Pharma Inc (NASDAQ:KITE) has “Buy” rating given on Monday, June 26 by Cowen & Co. The stock of Kite Pharma Inc (NASDAQ:KITE) has “Market Perform” rating given on Wednesday, February 22 by Wells Fargo.

Among 8 analysts covering Lundin Mining Corporation (TSE:LUN), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Lundin Mining Corporation had 71 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, August 21, the company rating was initiated by BMO Capital Markets. The stock of Lundin Mining Corporation (TSE:LUN) earned “Outperform” rating by RBC Capital Markets on Tuesday, April 11. The stock of Lundin Mining Corporation (TSE:LUN) earned “Focus Buy” rating by Scotia Capital on Friday, January 13. The firm earned “Hold” rating on Thursday, October 27 by TD Securities. The company was downgraded on Thursday, January 14 by Barclays Capital. The stock has “Outperform” rating by RBC Capital Markets on Thursday, December 3. Goldman Sachs upgraded Lundin Mining Corporation (TSE:LUN) on Wednesday, November 16 to “Buy” rating. The rating was maintained by RBC Capital Markets on Friday, September 2 with “Outperform”. The stock of Lundin Mining Corporation (TSE:LUN) has “Outperform” rating given on Friday, July 22 by RBC Capital Markets. On Monday, October 24 the stock rating was maintained by RBC Capital Markets with “Outperform”.

Lundin Mining Corporation is a diversified base metals mining company. The company has market cap of $5.39 billion. The Firm is engaged in mining, exploration and development of mineral properties, primarily in Chile, the United States, Portugal, Sweden and the Democratic Republic of Congo . It has a 25.91 P/E ratio. The Company’s divisions include Candeleria, Eagle, Neves-Corvo, Zinkgruvan, Tenke Fungurume and Other.